UBS lifted its price target on Patterson-UTI (Nasdaq: PTEN) from $14 to $17 following Q2 results, but is sticking with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE